Evidence map›Paper›PMID 41214713›Full record

ArticleJournal of translational medicine2025

Neuroglobin-promoted autophagy inhibits the proliferation, migration and invasion of human glioblastoma cells through the EGFR/PI3K/AKT/mTOR signaling pathway.

Li Li, Hongfeng Zhang, Wenqing Li, Zhijun Yuan, Wushi Zhao, Zhenzhao Luo

Abstract read
In one paragraph

Article in Journal of translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Li Li *Department of Pathology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430014, China.
Hongfeng Zhang *Department of Pathology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430014, China.
Wenqing Li *Department of Respiration, The Children's Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430015, China.
Zhijun Yuan *Department of Respiration, The Children's Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430015, China.
Wushi ZhaoDepartment of Medical Laboratory, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430014, China.
Zhenzhao LuoDepartment of Medical Laboratory, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430014, China. lzzbvy@163.com.ORCID 0000-0002-9463-9184

Funding

Guidance Project of Wuhan Municipal Health Commission WZ202122Health and Family Planning Commission of Gansu WX17Q10National Nature Science Foundation of China 81602198
6 · The paper itself

Abstract

backgroundNeuroglobin (Ngb) is a novel oxygen-binding or sensor protein that is present primarily in neurons and the brain. It plays a critical role in sensing oxygen and hypoxia signals and in transducing intracellular signaling pathways. However, the specific functions and mechanism of Ngb in the glioblastoma remain unclear.

methodsThe expression of Ngb in glioma brain tissues and cells was measured by Western blot, immunohistochemical staining and retrieved from TCGA databases. Loss or gain of function assays, CCK-8 assay, scratch and transwell assay, transmission electron microscopy (TEM) analysis, acridine orange staining, evaluation of fluorescent LC3 puncta, and flow cytometry analysis were conducted to determine the effects of Ngb overexpression or knockdown on glioblastoma multiforme (GBM) cell proliferation, invasion and autophagy, and Ngb/EGFR interactions were verified by glutathione S-Transferase (GST) pull-down assay and co-immunoprecipitation (Co-IP), and the mechanism of Ngb on autophagy was investigated by Western blot. The animal model of glioma was further employed to assess the inhibitory effect of Ngb overexpression on GBM cell growth.

resultsThe study demonstrated that the expression of Ngb was significantly downregulated in glioma tissues and cell lines and that its downregulation was positively correlated with poor patient survival, further demonstrating that Ngb promoted belcin1 and LC3-dependent autophagy in the GBM cells. We found that inhibitory effect of Ngb on cellular invasion is associated with the suppression of EGFR/PI3K/AKT/m-TOR signaling. Furthermore, our study revealed that increasing Ngb expression in GBM cells notably decreased their ability to migrate and invade in vitro and suppressed tumor growth in vivo. The overexpression of Ngb resulted in cell cycle arrest at the S phase and increased apoptosis. Finally, our findings indicated that Ngb increased autophagy, which may inhibit the invasion of glioblastoma multiforme (GBM) by interaction with the amino acid 1-42 domains of Ngb with EGFR.

conclusionsIn this study, our research findings indicated that Ngb promoted autophagy and suppressed the migration and invasion of GBM cells through inactivation of the EGFR/PI3K/AKT/m-TOR signaling pathway, highlighting that autophagy activation may suppress the invasion of GBM cells with low Ngb expression.

Indexed as

AutophagyBrain NeoplasmsCell MovementGlioblastomaNeuroglobinPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktSignal TransductionTOR Serine-Threonine KinasesAnimalsCell Line, TumorCell ProliferationErbB ReceptorsHumansMaleMice, NudeEGFR protein, humanErbB ReceptorsMTOR protein, humanNeuroglobinPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktTOR Serine-Threonine KinasesAutophagyGlioblastomaMigration and invasionNgbPI3K/AKT

Identifiers

PMID41214713
PMCPMC12599023

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.